Stockreport

BRIEF-Proteostasis Announces Formation Of Independent Steering Committee To Advise On Global Phase 3 Clinical Development Program For Pti-428 In Cystic Fibrosis [Reuters]

PROTEOSTASIS THERAPEUTICS  (PTI) 
Last proteostasis therapeutics earnings: 3/10 04:36 pm Check Earnings Report
US:NYSE Investor Relations: ir.proteostasis.com/investor-overview
PDF BRIEF-Proteostasis Announces Formation Of Independent Steering Committee To Advise On Global Phase 3 Clinical Development Program For Pti-428 In Cystic Fibrosis | Reuter [Read more]